Skip to main content
Clinical Trials/IRCT20240610062072N1
IRCT20240610062072N1RecruitingPhase 3

Comparing Magnesium Sulphate, Dexmedetomidine and Midazolam as adjuvant therapy to caudal Bupivacaine in postoperative analgesia in children undergoing lower abdominal surgery

Arak University of Medical Sciences0 sites90 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
90

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
2 years to 8 years (—)
Sex
All

Inclusion Criteria

  • All children between the ages of 2 to 8 years who are candidates for lower abdominal surgery
  • Children who are candidates for lower abdominal surgery who are electively referred to Valiasr, Amir al-Momenin and Amir Kabir hospitals.
  • Patients with ASA Class I, II
  • Duration of surgery between 30 and 90 minutes
  • Absence of seizure history, heart, lung, kidney and genetic diseases in patients who are candidates for surgery
  • Absence of diseases and mental disorders and mental and physical decline
  • Informed consent from the child's parents to participate in the study must be taken
  • No sensitivity to local anesthetics

Exclusion Criteria

  • Patients who care candidates for emergency lower abdominal surgery
  • Patients who are candidates for a surgery that lasts more than 90 minutes.
  • Patients who suffer cardio-respiratory arrest during surgery for any reason.
  • Patients who undergo multiple puncture in the process of caudal block.

Investigators

Similar Trials